BASF: Undervalued by 58%? A Deep Valuation Analysis

BASF Navigates Mixed Signals: Valuation Discrepancies and Strategic Shifts

Investors assessing BASF’s current valuation are encountering a complex picture. While a Discounted Cash Flow (DCF) analysis suggests the stock is significantly undervalued, other metrics point to a more nuanced, and potentially overvalued, position. Recent share price performance has also been mixed, with short-term declines offset by longer-term gains, adding to the uncertainty.

Currently trading around €46.00, BASF has seen a 4.9% decline over the past week and a 5.9% drop over the last month, according to recent analysis. However, the stock has delivered a 4.0% return over the past year and a more substantial 21.7% gain over three years. This divergence in performance underscores the challenges in interpreting the company’s current standing, particularly as it navigates cyclical risks inherent in the chemicals sector.

A key takeaway from Simply Wall St’s analysis is the disparity between different valuation approaches. The DCF model, which projects future free cash flow based on current estimates, arrives at an intrinsic value of approximately €110.27 per share. This suggests a substantial 58.3% discount to the current share price. However, when assessed using a Price-to-Earnings (P/E) ratio, BASF appears somewhat overvalued. Its current P/E of 28.04x exceeds both the industry average of 21.61x and the company’s “Fair Ratio” of 25.05x, as calculated by Simply Wall St.

This discrepancy highlights the importance of considering multiple valuation methods and understanding the underlying assumptions driving each. The P/E ratio, while useful, can be influenced by factors such as growth expectations and perceived risk. Simply Wall St’s Fair Ratio attempts to address these limitations by incorporating company-specific traits into the calculation.

BASF is actively pursuing a strategy of portfolio optimization, divesting lower-growth businesses like Decorative Paints and Coatings. The planned initial public offering (IPO) of its Agricultural Solutions division by 2027 is also expected to unlock value and streamline the company’s focus towards higher-margin segments. These strategic moves are intended to bolster earnings resilience and improve net margins.

Analysts, as compiled by Vara Research on March 12, 2026, project average sales of €15,764 million for Q1 2026, with EBITDA before special items reaching €2,206 million. Earnings per share are estimated at €0.95 (adjusted) and €1.05 (reported). These figures provide a snapshot of current expectations, but are subject to change based on market conditions and company performance.

Looking ahead, investors should monitor BASF’s progress in executing its strategic initiatives, particularly the Agricultural Solutions IPO. The success of these efforts will be crucial in determining whether the company can deliver on its potential and justify a higher valuation. Tracking broader trends in the chemicals sector, including regulatory changes and energy costs, will be essential for assessing BASF’s long-term outlook. The market’s perception of BASF’s ability to navigate these challenges will likely play a significant role in its future share price performance.

The range of fair value estimates, from a bullish €62.00 to a cautious €38.00, underscores the uncertainty surrounding BASF’s prospects. Investors are encouraged to develop their own narratives, based on their individual expectations for revenue growth, profit margins, and future earnings, to determine whether the current share price represents a genuine opportunity or a potential risk.